English Flag English العربية Flag العربية
 +(90) 5052646999   |    info@o9medical.com
O9medical | for Medical & consulting Logo
  • The best doctors in Turkey
  • Medical Oncology

Prof. Dr. Nuri Faruk Aykan

Prof. Dr. Nuri Faruk Aykan
Academic Title :
Prof. Dr.

Department Work location
Cancer Treatment Department Liv Bahcesehir

Prof. Dr. Nuri Faruk Aykan is a prominent specialist in MEDICAL ONCOLOGY at Liv Hospital Bahcesehir in Turkey. He has an illustrious academic and clinical career spanning decades, focusing on delivering advanced cancer care through state-of-the-art treatment protocols.

Education and Academic Qualifications

  • Doctor of Medicine (MD), Ankara University School of Medicine (Graduated first in class, 1976)
  • Specialization in Internal Medicine, Ankara University Faculty of Medicine (1981)
  • Research Studies in Genetic Manipulation, Strasbourg Louis Pasteur University, France (1981)
  • Subspecialty in Medical Oncology, Istanbul University Oncology Institute (1991)
  • European Board Certification in Medical Oncology, European Society for Medical Oncology (ESMO exam, Lyon, France, 1992)

Areas of Interest

  • Gastrointestinal cancers (colon, rectal, stomach, and pancreatic cancers)
  • Neuroendocrine tumors
  • Breast cancer
  • Lung cancer
  • Chemotherapy
  • Immunotherapy and targeted therapies

  • Professor, Istinye University, Liv Hospital Bahcesehir, Department of Medical Oncology (2017 - Present)
  • Professor, Istanbul University Oncology Institute, Division of Medical Oncology (1995 - 2017)
  • Associate Professor, Istanbul University Oncology Institute, Division of Medical Oncology (1988 - 1995)
  • Associate Professor, Ondokuz Mayis University Faculty of Medicine, Department of Internal Medicine, Samsun (1987 - 1988)
  • Assistant Professor, Ondokuz Mayis University Faculty of Medicine, Department of Internal Medicine, Samsun (1983 - 1987)
  • Research Fellow, Strasbourg Louis Pasteur University, France (1981)

  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)
  • European Society of Digestive Oncology (ESDO)

  • Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey (2022)
  • Biophysical Approach to Understand Life and Cancer (2024)
  • Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors? (2014)
  • Book Chapter: Body-mass Index and Health (2019)
  • Book Chapter: Current Frontiers and Perspectives in Cell Biology (2019)
Share :